Serum Aβ Levels as Predictors of Conversion to Mild Cognitive Impairment/Alzheimer Disease in an ADAPT Subcohort

Recent evidence suggests an association of β-amyloid (Aβ) with vascular risk factors and the medications to treat them, which could potentially obfuscate the usefulness of Aβ for prediction of mild cognitive impairment (MCI) or Alzheimer disease (AD). In a subcohort from the Alzheimer’s Disease Anti...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Asıl Yazarlar: Abdullah, Laila, Luis, Cheryl, Paris, Daniel, Mouzon, Benoit, Ait-Ghezala, Ghania, Keegan, Andrew P, Wang, Duolao, Crawford, Fiona, Mullan, Michael
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: ScholarOne 2009
Konular:
Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC2730348/
https://ncbi.nlm.nih.gov/pubmed/19707525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2119/molmed.2009.00083
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller